Telix Pharmaceuticals TLX
NASDAQ TLX
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Total Non-Current Liabilities (2023 - 2026)

Updated

Telix Pharmaceuticals' Total Non-Current Liabilities came in at $631.83 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Total Non-Current Liabilities was $516.99 million, unchanged from the prior year.

  • Going back by year, Total Non-Current Liabilities was $517.01 million in the year ended Dec 31, 2024 (+717.5%) and $63.24 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Telix Pharmaceuticals 3.84 Bn 2.78 Bn - 631.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 631.83 Mn
Dec 31, 2025 516.99 Mn
Dec 31, 2024 403.69 Mn
Dec 31, 2023 59.88 Mn
API Access

Telix Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TLX&period=max&api_key=YOUR_API_KEY